Company / FCF Margin
NOVAVAX INC FCF Margin History
FY2016-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-20.4%
FY2022
5-year range
-20.4% / 23.2%
FY2018-FY2022
Trend
-188.1%
vs FY2021
Sector context
#74 of 133
Health Care
What the data says
At -20.4%, NOVAVAX INC's fcf margin ranks #74 of 133 in the Health Care sector.
Based on SEC 10-K filings.
-20.4% in FY2022 with a 5-year CAGR of +377.8%.
Remained stable around -20.4% over the past 2 years.
Health Care sector context is included.
FCF Margin over time
Growth rates
- 3-Year Change
- +456.5pp
- 5-Year Change
- +377.8pp
- 10-Year Change
- -
Sector benchmark
#74 of 133 in Health CareTop 56% of 133This company -20.4% Sector average -632.8%
▼
+96.8% above sector average
Key checks
Key Insights
- In FY2022, fcf margin decreased 188.1% year-over-year.
- Currently 612.4pp above the Health Care sector average.
- Peak fcf margin was recorded in FY2021.
- Lowest fcf margin in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -0.87 (distress zone, below 1.8 threshold)
- Negative profit margin: -27.5%
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | -20.4% | -188.1% |
| FY2021 | 23.2% | +213.4% |
| FY2020 | -20.4% | +95.7% |
| FY2019 | -476.9% | +73.6% |
| FY2018 | -1804.0% | -353.0% |
| FY2017 | -398.2% | -64.4% |
| FY2016 | -242.3% | +0.9% |
As of FY2022 · SEC 10-K · Updated Jun 30, 2026